Vasamed Company Top Management

VSMD Stock  USD 0.0001  0.00  0.00%   
Vasamed employs about 11 people. The company is managed by 5 executives with a total tenure of roughly 48 years, averaging almost 9.0 years of service per executive, having 2.2 employees per reported executive. Evaluation of Vasamed's management performance can provide insight into the firm performance.
Paulita LaPlante  CEO
CEO and President and Director
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vasamed. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Vasamed Management Team Effectiveness

The company has return on total asset (ROA) of (0.741) % which means that it has lost $0.741 on every $100 spent on assets. This is way below average. Vasamed's management efficiency ratios could be used to measure how well Vasamed manages its routine affairs as well as how well it operates its assets and liabilities.
About 99.7 % of Vasamed outstanding shares are held by general public with 0.3 % by institutional holders.
Some institutional investors establish a significant position in pink sheets such as Vasamed in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Vasamed, and when they decide to sell, the pink sheet will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

Vasamed Workforce Comparison

Vasamed is rated first in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 50.0. Vasamed totals roughly 11.0 in number of employees claiming about 22% of equities under Health Care industry.
The company has Profit Margin (PM) of (0.56) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.47) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.47.

Vasamed Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Vasamed Price Series Summation is a cross summation of Vasamed price series and its benchmark/peer.

Vasamed Notable Stakeholders

A Vasamed stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Vasamed often face trade-offs trying to please all of them. Vasamed's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Vasamed's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Paulita LaPlanteCEO and President and DirectorProfile
Roberta DircksCFO and VP of Fin. and Admin.Profile
Michael SchreiberPres CEOProfile
Wesley PetersonSecProfile
Daniel BartnikCTO OperationsProfile
String symbol = request.getParameter("s");

About Vasamed Management Performance

The success or failure of an entity such as Vasamed often depends on how effective the management is. Vasamed management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Vasamed management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Vasamed management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Vasamed Incorporated designs, licenses, manufactures, and distributes products, software, and services for assessing and managing hemodynamic health in the United States. The company was founded in 1988 and is headquartered in Eden Prairie, Minnesota. Vasamed operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange.
Please note, the presentation of Vasamed's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Vasamed's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Vasamed's management manipulating its earnings.

Vasamed Workforce Analysis

Traditionally, organizations such as Vasamed use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Vasamed within its industry.

Vasamed Manpower Efficiency

Return on Vasamed Manpower

Revenue Per Employee285K
Revenue Per Executive626.9K
Net Loss Per Employee265.9K
Net Loss Per Executive585K
Working Capital Per Employee13K
Working Capital Per Executive28.6K

Complementary Tools for Vasamed Pink Sheet analysis

When running Vasamed's price analysis, check to measure Vasamed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vasamed is operating at the current time. Most of Vasamed's value examination focuses on studying past and present price action to predict the probability of Vasamed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vasamed's price. Additionally, you may evaluate how the addition of Vasamed to your portfolios can decrease your overall portfolio volatility.
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators